1Allen RH,Robert AC,Philip SB. Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa[J].Pharm Res,1990,7(9):902.
2Gan LL,Dhiren RT.Applications of the Caco-2 model in the design and development of orally active drugs:elucidation of biochemical and physical barriers posed by the intestinal epithelium[J].Adv Drug Deliv Rev,1997,23(1):77.
3Hidalgo IJ,Raub TJ,Borchardt RT.Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability[J].Gastroenterology,1989,96(3):736.
4Artursson P,Karlsson J.Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells[J].Bioche Biophy Res Commun,1991,175(3):880.
5Yee S.In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-fact or myth[J].Pharm Res,1997,14(6):763.
6Hillgren KM,Kato A,Borchardt RT.In vitro systems for studying intestinal drug absorption[J].Med Res Rev,1995,15(1):83.
7Liu DZ,Morris-Natschke SL,Kucera LS,et al.Structure-activity relationships for enhancement of paracellular permeability by 2-alkoxy-3-alkylamidopropylphosphocholines across Caco-2 cell monolayers[J].J Pharm Sci,1999,88(11):1169.
8Jezyk N,Li C,Stewart BH,et al. Transport of pregabalin in rat intestine and Caco-2 monolayers[J].Pharm Res,1999,16(4):519.
9Dimitrijevic D,Shaw AJ,Florence AT.Effects of some non-ionic surfactants on transepithelial permeability in Caco-2 cells[J].J Pharm Pharmacol,2000,52(2):157.
10Lee K,Thakker DR.Saturable transport of H2-antagonists ranitidine and famotidine across Caco-2 cell monolayers[J].J Pharm Sci,1999,88(7):680.
